Discovering the Potentials of Four Phage Endolysins to Combat Gram-Negative Infections.
Ontology highlight
ABSTRACT: Endolysin-based therapeutics are promising antibacterial agents and can successfully supplement the existing antibacterial drugs array. It is specifically important in the case of Gram-negative pathogens, e.g., ESKAPE group bacteria, which includes Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species, and are highly inclined to gain multiple antibiotic resistance. Despite numerous works devoted to the screening of new lytic enzymes and investigations of their biochemical properties, there are significant breaches in some aspects of their operating characteristics, including safety issues of endolysin use. Here, we provide a comprehensive study of the antimicrob
SUBMITTER: Vasina DV
PROVIDER: S-EPMC8548769 | biostudies-literature | 2021
REPOSITORIES: biostudies-literature
ACCESS DATA